Clinical Trial Update: Safety and Efficacy of Heparin and Nadroparin in the Acute Phase of Ischemic Stroke [Phase 4]

View source ↗

Summary

This Phase 4 trial update reports on the safety and efficacy of heparin and nadroparin in the acute phase of ischemic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Heparin (unfractionated heparin)
• Nadroparin (nadroparin sodium)

Snippet

Sponsor: University Hospital, Martin | Conditions: Acute Ischemic Stroke | Phase 4 | Status: UNKNOWN